These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 35789021)

  • 1. Decreased severity of COVID-19 in vaccinated pregnant individuals during predominance of different SARS-CoV-2 variants.
    Eid J; Abdelwahab M; Williams H; Caplan M; Hajmurad S; Venkatesh KK; Costantine MM; Rood KM
    Am J Reprod Immunol; 2022 Sep; 88(3):e13596. PubMed ID: 35789021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced control of SARS-CoV-2 infection associates with lower mucosal antibody responses in pregnancy.
    St Clair LA; Eldesouki RE; Sachithanandham J; Yin A; Fall A; Morris CP; Norton JM; Abdullah O; Dhakal S; Barranta C; Golding H; Bersoff-Matcha SJ; Pilgrim-Grayson C; Berhane L; Cox AL; Burd I; Pekosz A; Mostafa HH; Klein EY; Klein SL
    mSphere; 2024 Mar; 9(3):e0081223. PubMed ID: 38426787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant Women.
    Goldshtein I; Nevo D; Steinberg DM; Rotem RS; Gorfine M; Chodick G; Segal Y
    JAMA; 2021 Aug; 326(8):728-735. PubMed ID: 34251417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 vaccine effectiveness in preventing confirmed infection in pregnant women.
    Butt AA; Chemaitelly H; Al Khal A; Coyle PV; Saleh H; Kaleeckal AH; Latif AN; Bertollini R; Abou-Samra AB; Abu-Raddad LJ
    J Clin Invest; 2021 Dec; 131(23):. PubMed ID: 34618693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Influenza Vaccination and SARS-CoV-2 Infection.
    Ma'ayeh M; de Voest JA; Hughes BL; Grobman WA; Saade GR; Manuck TA; Longo M; Simhan HN; Rouse DJ; Mendez-Figueroa H; Gyamfi-Bannerman C; Bailit JL; Costantine MM; Sehdev HM; Tita ATN; Metz TD;
    Am J Reprod Immunol; 2024 Jul; 92(1):e13896. PubMed ID: 38994889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study.
    Chia PY; Ong SWX; Chiew CJ; Ang LW; Chavatte JM; Mak TM; Cui L; Kalimuddin S; Chia WN; Tan CW; Chai LYA; Tan SY; Zheng S; Lin RTP; Wang L; Leo YS; Lee VJ; Lye DC; Young BE
    Clin Microbiol Infect; 2022 Apr; 28(4):612.e1-612.e7. PubMed ID: 34826623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination effects on reducing COVID-19 complications in pregnancy: A large-scale report from Iran.
    Changizi N; Eshrati B; Salehi M; Beheshtian M; Hadipour Jahromy L; Emami Afshar N; Hejazi S; Hantoushzadeh S; Eslamian L; Savaie M; Raeisi A; Pooransari P
    Int J Gynaecol Obstet; 2023 Dec; 163(3):1012-1017. PubMed ID: 37655467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of SARS-CoV-2 vaccination during pregnancy- obstetric outcomes from a large cohort study.
    Dick A; Rosenbloom JI; Gutman-Ido E; Lessans N; Cahen-Peretz A; Chill HH
    BMC Pregnancy Childbirth; 2022 Feb; 22(1):166. PubMed ID: 35227233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of COVID-19 Vaccination During Pregnancy With Incidence of SARS-CoV-2 Infection in Infants.
    Carlsen EØ; Magnus MC; Oakley L; Fell DB; Greve-Isdahl M; Kinge JM; Håberg SE
    JAMA Intern Med; 2022 Aug; 182(8):825-831. PubMed ID: 35648413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of COVID-19 vaccination during pregnancy by circulating viral variant.
    Zerbo O; Ray GT; Fireman B; Layefsky E; Goddard K; Ross P; Greenberg M; Klein NP
    AJOG Glob Rep; 2023 Nov; 3(4):100264. PubMed ID: 37719643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of SARS-CoV-2 infection and vaccination on cesarean section outcomes: a retrospective analysis.
    Yeniocak AS; Tercan C; Dagdeviren E; Arabaci O; Arabaci EEG
    Ann Saudi Med; 2024; 44(5):306-318. PubMed ID: 39368119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Vaccination Status and Outcomes in Patients Admitted to the ICU With COVID-19.
    van Diepen S; McAlister FA; Chu LM; Youngson E; Kaul P; Kadri SS
    Crit Care Med; 2023 Sep; 51(9):1201-1209. PubMed ID: 37192450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmission and Infectious SARS-CoV-2 Shedding Kinetics in Vaccinated and Unvaccinated Individuals.
    Jung J; Kim JY; Park H; Park S; Lim JS; Lim SY; Bae S; Lim YJ; Kim EO; Kim J; Park MS; Kim SH
    JAMA Netw Open; 2022 May; 5(5):e2213606. PubMed ID: 35608859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical features of children with coronavirus disease 2019 Delta variant infection after vaccination with inactivated SARS-CoV-2 vaccine].
    Su H; Zhang X; Duan FY; Ren XQ; Yan YB; Ding Y
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 Jul; 24(7):742-747. PubMed ID: 35894187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
    Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Covid-19 vaccination and pregnancy: a systematic review of maternal and neonatal outcomes.
    Kontovazainitis CG; Katsaras GN; Gialamprinou D; Mitsiakos G
    J Perinat Med; 2023 Sep; 51(7):823-839. PubMed ID: 36800343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of vaccination on the symptoms of hospitalised patients with SARS-CoV-2 Delta variant (B.1.617.1) infection.
    Epaulard O; Abgrall S; Lefebvre M; Faucher JF; Michon J; Frentiu E; Blanchi S; Janssen C; Charbonnier G; Fresse A; Laurent S; Sandjakian L; Casez P; Mahamat A; Beraud G
    Clin Microbiol Infect; 2022 Dec; 28(12):1629-1635. PubMed ID: 35779764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rate and Risk Factors for Severe/Critical Disease Among Fully Vaccinated Persons With Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a High-Risk National Population.
    Butt AA; Yan P; Shaikh OS; Mayr FB; Omer SB
    Clin Infect Dis; 2022 Aug; 75(1):e849-e856. PubMed ID: 34893812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased maternal mortality in unvaccinated SARS-CoV-2 infected pregnant patients.
    Atak Z; Rahimli Ocakoglu S; Topal S; Macunluoglu AC
    J Obstet Gynaecol; 2022 Oct; 42(7):2709-2714. PubMed ID: 35852931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of SARS-Cov-2 mRNA vaccine on placental histopathology: Comparison of a population of uncomplicated COVID-19 positive pregnant women.
    Tartaglia S; Di Ilio C; Romanzi F; Moresi S; Nardi E; Bevilacqua E; Arena V; Lanzone A
    Placenta; 2024 Apr; 149():64-71. PubMed ID: 38527377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.